Highlights on Novel Technologies for the Detection of Antibodies to Ro60, Ro52, and SS-B

Table 3

Overview of discrepant samples sorted according to disease state.

Sample ID	Diagnosis	QUANTRIX (cut-off = 6 U/mL)	D-tek Dot Blot	QUANTA Flash Ro52 (cut-off = 20 CU)	BioPlex 2200 (Ro52) (cut-off = 1.0)
ASX~0039	SjS	Not tested	1	30.2	0.2
ASX~0068	SjS	12	1	30.8	0.5
BEx0026	SjS	12	1	25	0.7
BEx0042	SjS	14	1	27.6	0.9
BEx0040	SLE	7	1	24.3	0.2
BEx0046	UCTD	10	1	56.4	0.4
BEx0058	UCTD	0	0	21.4	0.2
ASX~0088	RA	40	1	254.9	0.2
BSX0053	RA	Not tested	1	200.2	0.2
BSX0056	RA	Not tested	1	55.6	0.2
BSX0035	AT	Not tested	0	69.2	0.2
Sample ID	Diagnosis	QUANTRIX (cut-off = 6 U/mL)	D-tek Dot Blot	QUANTA Flash Ro60 (cut-off = 20 CU)	BioPlex 2200 (Ro60) (cut-off = 1.0)
BEx0006	UCTD	Not tested	0	4.9	8
BEx0051	UCTD	0	0	4.9	1.2
BEx0056	UCTD	0	0	8.2	1.1
Sample ID	Diagnosis	QUANTRIX (cut-off = 6 U/mL)	D-tek Dot Blot	QUANTA Flash SSB (cut-off = 20 CU)	BioPlex 2200 (SSB) (cut-off = 1.0)
BEx0001	SjS	0	0	8.4	3
BEx0014	SjS	0	0	24.8	0.9
BEx0035	SjS	0	0	13.1	8
BEx0036	SjS	Not tested	Not tested	25.5	0.2
ASX~0076	SLE	0	0	16.6	8
ASX~0082	SLE	0	0	8.5	8
BEx0054	SLE	0	0	3.3	1
BEx0013	UCTD	Not tested	0	4.2	8
BEx0022	UCTD	0	0	3.3	1.2
BEx0030	UCTD	Not tested	0	3.3	8
BEx0033	UCTD	Not tested	1	225.8	0.2
BEx0037	UCTD	0	0	5.3	1.9
BEx0058	UCTD	0	0	5.5	1.2
BEx0067	UCTD	0	0	5.1	4.7
BEx0068	UCTD	0	0	3.3	1.8
BEx0069	UCTD	0	0	3.3	2.7
ASX~0098	RA	0	0	3.3	1.2
BEx0060	RA	0	0	16	2.4
BSX0043	RA	0	0	3.3	4.2
BSX0091	HI	0	0	3.3	1.1

AT: atopic dermatitis; HI: healthy individual; UCTD: undifferentiated connective tissue disease; RA: rheumatoid arthritis; SjS: Sjögren syndrome; SLE: systemic lupus erythematosus.